Shionogi, JP3347200002

Shionogi announces EU approval as Shionogi stock sits 19.60 percent below its high

Published on 10/05/2026 at 06:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue reached USD 1.04 billion versus USD 970.69 million consensus. Shionogi stock traded EUR 16.24 on October 2, 2026 after EUR 16.10.

Shionogi, JP3347200002, Illustration mit AI erstellt.

Shionogi & Co. (JP3347200002) announced European Commission approval for Zokovea on September 28, 2026, while Shionogi stock last stood 19.60 percent below its Tradegate 52-week high of EUR 20.20. The approval covers post-exposure prevention of COVID-19 in adults and adolescents aged 12 years and older.

European approval expands Zokovea use

According to Shionogi on September 28, 2026, Zokovea became the first oral antiviral authorized in the European Union for post-exposure prophylaxis of COVID-19. The decision was supported by the Phase 3 SCORPIO-PEP study, in which the treatment reduced the risk of symptomatic COVID-19 through Day 10 by 67.00 percent versus placebo.

The company said the study included 2,387 participants and began treatment within 72 hours of a household member developing symptoms. Shionogi markets ensitrelvir as Zokovea in the European Union and as Xocova in Japan and the United States.

Revenue beats first-quarter consensus

MarketBeat reported on September 10, 2026 that Shionogi posted USD 1.04 billion in revenue for the first quarter ended June 30, 2026, above the USD 970.69 million consensus. Reported earnings per share were USD 0.36, compared with the USD 0.18 consensus, a USD 0.18 difference.

The result gives the regulatory announcement a financial backdrop: infectious-disease products remain central to Shionogi's growth profile, while the European authorization creates an additional use case for an existing antiviral platform. The approval itself does not quantify future sales, so the first-quarter revenue and earnings comparison remain the clearest measured indicators in the latest reported period.

Stock remains below its yearly high

Shionogi stock last traded at EUR 16.24 on Tradegate on October 2, 2026, versus a prior close of EUR 16.10. The price was 19.60 percent below the EUR 20.20 52-week high and 24.00 percent above the EUR 13.10 52-week low.

Shionogi's primary listing is the Tokyo Stock Exchange, where ticker 4507 was quoted at JPY 2,772.50 on October 5, 2026 at 3:44 a.m. CEST, down 0.48 percent from JPY 2,786.00. That primary-exchange figure is separate from the euro reference price used for German investors.